C/EBPalpha: a tumour suppressor in multiple tissues?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
C/EBPalpha: a tumour suppressor in multiple tissues? / Schuster, Mikkel Bruhn; Porse, Bo Torben.
In: BBA General Subjects, Vol. 1766, No. 1, 2006, p. 88-103.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - C/EBPalpha: a tumour suppressor in multiple tissues?
AU - Schuster, Mikkel Bruhn
AU - Porse, Bo Torben
N1 - Keywords: Animals; CCAAT-Enhancer-Binding Protein-alpha; Genes, Tumor Suppressor; Humans; Neoplasms; Tissue Distribution
PY - 2006
Y1 - 2006
N2 - The CCATT/enhancer binding protein alpha, C/EBPalpha, is a key transcription factor involved in late differentiation events of several cell types. Besides acting as a classical transcription factor, C/EBPalpha is also a well-characterized inhibitor of mitotic growth in most cell lines tested. In line with its anti-mitotic properties, C/EBPalpha has been shown to interact with, and alter the activities of, several cell cycle related proteins and a number of models as to the mechanistics of C/EBPalpha-mediated growth repression have been proposed. More recently, several reports have indicated that C/EBPalpha acts as a tumour suppressor in the hematopoietic system and that mutation within C/EBPalpha is sufficient to induce tumourigenesis. Here, we will review these data and probe the possibility that C/EBPalpha also act as a tumour suppressor in other C/EBPalpha-expressing tissues.
AB - The CCATT/enhancer binding protein alpha, C/EBPalpha, is a key transcription factor involved in late differentiation events of several cell types. Besides acting as a classical transcription factor, C/EBPalpha is also a well-characterized inhibitor of mitotic growth in most cell lines tested. In line with its anti-mitotic properties, C/EBPalpha has been shown to interact with, and alter the activities of, several cell cycle related proteins and a number of models as to the mechanistics of C/EBPalpha-mediated growth repression have been proposed. More recently, several reports have indicated that C/EBPalpha acts as a tumour suppressor in the hematopoietic system and that mutation within C/EBPalpha is sufficient to induce tumourigenesis. Here, we will review these data and probe the possibility that C/EBPalpha also act as a tumour suppressor in other C/EBPalpha-expressing tissues.
U2 - 10.1016/j.bbcan.2006.02.003
DO - 10.1016/j.bbcan.2006.02.003
M3 - Journal article
C2 - 16616425
VL - 1766
SP - 88
EP - 103
JO - B B A - General Subjects
JF - B B A - General Subjects
SN - 0304-4165
IS - 1
ER -
ID: 5140564